Thanks @LeftYahoo and @otherperspective - great posts as usual.
One question that has been nagging at me.
"This is a SEISMIC shift to my mind and underlines perhaps a deeper significance of the CHF study that few seen to have perceived: rex-L may ultimately have a greater role as a prophylactic than as a traditional therapeutic." and that can be extended to Rem-L for C19 ARDS too as our sweet spot is no longer the "sickest of the sick" patients...
A long way to go, but will the industry/ insurers (i.e. Pharmacoeconomic) support such a costly preventative treatment?
Costs associated with preventative measures have a different value to the actual treatment itself, at least to the patients.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
34.6%
!
$2.41

Cell Therapy News/Articles, page-8233
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.41 |
Change
0.620(34.6%) |
Mkt cap ! $3.084B |
Open | High | Low | Value | Volume |
$1.90 | $2.48 | $1.90 | $58.82M | 25.68M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 100915 | $2.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.41 | 99 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4500 | 2.380 |
1 | 10000 | 2.360 |
2 | 15500 | 2.350 |
1 | 300 | 2.340 |
1 | 250 | 2.330 |
Price($) | Vol. | No. |
---|---|---|
2.420 | 6350 | 2 |
2.430 | 25000 | 2 |
2.440 | 7000 | 1 |
2.450 | 67300 | 5 |
2.460 | 3225 | 2 |
Last trade - 16.12pm 18/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |